Danaher (NYSE:DHR) Given New $215.00 Price Target at Barclays

Danaher (NYSE:DHR - Get Free Report) had its target price lifted by equities researchers at Barclays from $205.00 to $215.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an "overweight" rating on the conglomerate's stock. Barclays's price objective points to a potential upside of 11.94% from the company's previous close.

Other equities analysts also recently issued reports about the company. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research note on Friday, March 14th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Robert W. Baird set a $231.00 price objective on shares of Danaher in a research note on Wednesday, April 16th. JPMorgan Chase & Co. cut their target price on shares of Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Finally, Citigroup reiterated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Four research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $271.55.

Danaher Price Performance

Shares of DHR traded up $7.10 during mid-day trading on Tuesday, hitting $192.06. The company's stock had a trading volume of 6,684,869 shares, compared to its average volume of 3,348,710. The firm has a 50-day simple moving average of $201.64 and a 200 day simple moving average of $226.01. Danaher has a 1-year low of $171.00 and a 1-year high of $281.70. The firm has a market capitalization of $137.27 billion, a P/E ratio of 36.38, a P/E/G ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Analysts predict that Danaher will post 7.63 EPS for the current fiscal year.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 11.10% of the company's stock.

Hedge Funds Weigh In On Danaher

Large investors have recently bought and sold shares of the stock. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after acquiring an additional 2,202 shares during the period. ORG Partners LLC lifted its position in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after acquiring an additional 2,559 shares in the last quarter. Generate Investment Management Ltd purchased a new position in Danaher during the 4th quarter worth approximately $8,044,000. Compass Capital Management Inc. boosted its position in shares of Danaher by 4.8% in the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after buying an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC increased its holdings in shares of Danaher by 42.8% in the 4th quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock valued at $1,301,000 after purchasing an additional 1,698 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.